Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nucleus Network Brisbane, Brisbane, Queensland, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Royal Melbourne Hospital, Parkville, Victoria, Australia
Contact: Study coordinator (Jeff Szer, MD) · PCCTU.HaemA@petermac.org · +61385595000
Richmond Pharmacology Ltd, London, London, United Kingdom

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor

Paroxysmal Nocturnal Hemoglobinuria (PNH) · Persistent Anemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Toronto, Canada · Suwon, South Korea

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Severe Aplastic Anemia (SAA) · Hypo-Plastic Myelodysplastic Syndrome (MDS) · Paroxysmal Nocturnal Hemoglobinuria (PNH)

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH) · Paroxysmal Hemoglobinuria

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Prague, Czechia

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

Severe Aplastic Anemia · Acquired Amegakaryocytic Thrombocytopenia · Acquired Pure Red Cell Aplasia

Abroad (travel likely)RecruitingPHASE2

Minneapolis, United States